Desensitization in live kidney donor recipients provides good outcome at mid-term follow-up

Basit Öğe Kaydı
dc.authoridMahmut Nezih Çarin / 0000-0003-2826-5871
dc.authorscopusidMahmut Nezih Çarin / 6701662995
dc.authorwosidMahmut Nezih Çarin / IKG-4863-2023
dc.contributor.authorApaydın, Süheyla
dc.contributor.authorKasapoğlu, Umut
dc.contributor.authorAkbay, Fatih Gökhan
dc.contributor.authorKayalar, Arzu Özdemir
dc.contributor.authorKudu, Ayşegül
dc.contributor.authorDikeç, Mehmet
dc.contributor.authorDeğer, Günden
dc.contributor.authorToprak, Zeki
dc.contributor.authorÇarin, Mahmut Nezih
dc.date.accessioned2020-09-15T07:08:15Z
dc.date.available2020-09-15T07:08:15Z
dc.date.issued2020
dc.departmentİstinye Üniversitesi, Rektörlüken_US
dc.description.abstractThe recipients who have antibodies againts to donors’ HLA (Anti HLA- DSA) carrie a huge risk for allograf (AG) losing. In current study, it was retrospectively evaluated whether the live donor kidney recipients (LDKRs) under desensitization (DS) were exposed to more AG loss, lower AG survival and more complications.en_US
dc.identifier.citationAPAYDIN, S., KASAPOGLU, U., AKBAY, F. G., Ozdemir Kayalar, A., KUDU, A., Dikec, M., ... & CARIN, M. (2020). P1787 DESENSITIZATION IN LIVE KIDNEY DONOR RECIPIENTS PROVIDES GOOD OUTCOME AT MID-TERM FOLLOW-UP. Nephrology Dialysis Transplantation, 35(Supplement_3), gfaa142-P1787.en_US
dc.identifier.endpage2103en_US
dc.identifier.issn0931-0509en_US
dc.identifier.issueSupplement: 3en_US
dc.identifier.startpage2103en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12713/1020
dc.identifier.volume35en_US
dc.identifier.wosWOS:000562392101842en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorÇarin, Mahmut Nezih
dc.language.isoenen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.relation.ispartofNEPHROLOGY DIALYSIS TRANSPLANTATIONen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleDesensitization in live kidney donor recipients provides good outcome at mid-term follow-upen_US
dc.typeConference Objecten_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
24.pdf
Boyut:
87.76 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Doku Tipleme ve İmmünoloji Merkezi Bildiri Koleksiyonu